Clinical Trials Directory

Trials / Completed

CompletedNCT07103577

Guided Island Osteoperiosteal Flap Versus Ridge Splitting for Anterior Atrophic Maxillary

Guided Island Osteoperiosteal Flap Versus Ridge Splitting for Anterior Atrophic Maxillary Augmentation With Implant Placement (a Randomized Controlled Clinical Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Background: After tooth extraction changes of the shape of the alveolar bone follows a predictable pattern, which proves to be challenging in restoring its form and function, especially in the esthetic zone. Autogenous grafts remain the gold standard because of their predictability. The island osteoperiosteal flap (I-flap) is introduced as a modified alveolar split bone grafting technique used to gain width, height and modify the facial or buccal bone plate position. Aim of the study: This study aims to evaluate in anterior atrophic maxillary ridge augmentation using guided unreflected island osteoperiosteal flap (I-Flap) approach with simultaneous implant placement and interpostional bone grafting in comparison to computer guided ridge splitting method.

Conditions

Interventions

TypeNameDescription
PROCEDUREIsland osteoperiosteal flapCrestal incision using no. 15 blade on a bard parker no. 3. Two blind lateral vertical ostotomies at about 1.5 to 2 mm from the adjacent tooth roots to preserve subpapillary and root bone coverage. These cuts are to ensure the complete fracture of buccal plate while being attached to the overlying periosteum.
PROCEDUREConventional ridge splittingCrestal incision and 2 vertical releasing incisions will be made using a no.15 blade mounted on a Bard Parker no.3. Then, a full mucoperiosteal flap reflection to expose bone.

Timeline

Start date
2023-11-05
Primary completion
2025-05-13
Completion
2025-05-13
First posted
2025-08-05
Last updated
2025-08-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07103577. Inclusion in this directory is not an endorsement.